Discovery of candidate tumor biomarkers for treatment with intraperitoneal chemotherapy for ovarian...
Discovery of candidate tumor biomarkers for treatment with intraperitoneal chemotherapy for ovarian cancer
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Tumor mRNA expression was used to discover genes associated with worse survival or no survival benefit after intraperitoneal (IP) chemotherapy. Data for high grade serous ovarian cancer patients treated with IP (n = 90) or IV-only (n = 398) chemotherapy was obtained from The Cancer Genome Atlas. Progression free survival (PFS) and overall survival...
Alternative Titles
Full title
Discovery of candidate tumor biomarkers for treatment with intraperitoneal chemotherapy for ovarian cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4756718
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4756718
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/srep21591
